Series A Final

Series A Final

SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform

Summer 2019 Press Release

Summer 2019 Press Release

SEngine Precision Medicine Announces Experienced Technology Executive Tom Neary as Chief Financial Officer

Newsletter- Celebrating Growth & Major Milestones

Newsletter- Celebrating Growth & Major Milestones

We look forward to updating you quarterly on our progress as we work together to fulfill our vision of a future when every cancer patient receives personalized, effective and less-toxic treatment.

Newsletter

Newsletter

Learn about new partnerships, additions to our growing team, progress in efforts to advance new drugs and other company news in SEngine Precision Medicine quarterly newsletter.

Fall 2018 Press Release

Fall 2018 Press Release

SEngine Welcomes Nobel Prize Winner and Former Fred Hutch Cancer Research Center President Dr. Leland Hartwell to Join Board of Directors